Bone Biologics Selects Cytovance Biologics For cGMP Manufacturing Of Its Breakthrough Bone And Cartilage Regeneration Therapy

Published: Feb 13, 2007

OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance® Biologics LLC, a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from mammalian cell culture, today announced the addition of Bone Biologics, Inc. to its diverse and growing client portfolio. Bone Biologics has selected Cytovance for process development and cGMP manufacturing of its breakthrough recombinant protein for spinal fusion surgery.

Back to news